17 results
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
12 Jul 22
Agios Appoints Brian Goff as Chief Executive Officer
4:14pm
,” said Dr. Fouse. “The time is right to evolve our leadership and deepen our genetically defined disease skill set to further drive our ability
DEFA14A
9nrn 4su5
21 Dec 20
Additional proxy soliciting materials
5:21pm
DEFA14A
EX-99.1
fmy2d
21 Dec 20
Additional proxy soliciting materials
7:10am
8-K
EX-99.1
7wfu14xmo6c7p1
21 Dec 20
Regulation FD Disclosure
7:04am
S-3ASR
EX-4.4
lc8x01wp0 j4
30 Apr 20
Automatic shelf registration
4:19pm
S-3ASR
EX-4.5
pd7ttl63ya q23t3a
30 Apr 20
Automatic shelf registration
4:19pm
S-3ASR
ykr2hqbm18d1
30 Apr 20
Automatic shelf registration
4:19pm
424B5
83ng6en38rqpn
8 Nov 19
Prospectus supplement for primary offering
5:03pm
424B5
ymbylboi
6 Nov 19
Prospectus supplement for primary offering
4:07pm
424B5
tm3qgwiu a6qdj2e
11 Dec 14
Prospectus supplement for primary offering
12:00am
424B5
omyd4r1r0iz9k5frxtj
9 Dec 14
Prospectus supplement for primary offering
12:00am
- Prev
- 1
- Next